{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:02:28Z","timestamp":1780743748000,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110344","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:51:46Z","timestamp":1780743106000},"source":"Crossref","is-referenced-by-count":0,"title":["Advances in the Diagnosis and Management of Acute Coronary Syndrome: A Clinical Review"],"prefix":"10.7759","author":[{"given":"Anand Sekar","family":"G","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga Prasad","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagyesh","family":"Darji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhilesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00884-0","article-title":"Global epidemiology of acute coronary syndromes","volume":"20","author":"Timmis A","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023, 20:778-788. 10.1038\/s41569-023-00884-0","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar F","year":"2016","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016, 4:256. 10.21037\/atm.2016.06.33","journal-title":"Ann Transl Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.30574\/wjarr.2024.21.1.0352","article-title":"Acute coronary syndrome: definition, pathophysiology, diagnosis, and management","volume":"21","author":"Estrada EA","year":"2024","unstructured":"Estrada EA, Sequeda ER, Barros JE, R\u00edos JA, Segura IM, Barreto GL. Acute coronary syndrome: definition, pathophysiology, diagnosis, and management. World J Adv Res Rev. 2024, 21:2537-2548. 10.30574\/wjarr.2024.21.1.0352","journal-title":"World J Adv Res Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X18666220411113450","article-title":"Synopsis of biomarkers of atheromatous plaque formation, rupture and thrombosis in the diagnosis of acute coronary syndromes","volume":"18","author":"Udaya R","year":"2022","unstructured":"Udaya R, Sivakanesan R. Synopsis of biomarkers of atheromatous plaque formation, rupture and thrombosis in the diagnosis of acute coronary syndromes. Curr Cardiol Rev. 2022, 18:53-62. 10.2174\/1573403X18666220411113450","journal-title":"Curr Cardiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00542-3","article-title":"Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions","volume":"18","author":"Fahed AC","year":"2021","unstructured":"Fahed AC, Jang IK. Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions. Nat Rev Cardiol. 2021, 18:724-734. 10.1038\/s41569-021-00542-3","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/life13071543","article-title":"Pathophysiology of acute coronary syndromes\u2014diagnostic and treatment considerations","volume":"13","author":"Theofilis P","year":"2023","unstructured":"Theofilis P, Oikonomou E, Chasikidis C, Tsioufis K, Tousoulis D. Pathophysiology of acute coronary syndromes\u2014diagnostic and treatment considerations. Life (Basel). 2023, 13:1543. 10.3390\/life13071543","journal-title":"Life (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.711453","article-title":"Plaque erosion: a distinctive pathological mechanism of acute coronary syndrome","volume":"8","author":"Luo X","year":"2021","unstructured":"Luo X, Lv Y, Bai X, et al.. Plaque erosion: a distinctive pathological mechanism of acute coronary syndrome. Front Cardiovasc Med. 2021, 8:711453. 10.3389\/fcvm.2021.711453","journal-title":"Front Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cells15010072","article-title":"Inflammatory mechanisms in acute coronary syndromes: from pathophysiology to therapeutic targets","volume":"15","author":"Brie DM","year":"2025","unstructured":"Brie DM, Morno\u0219 C, Adam O, T\u00eerziu A, Popescu R, Brie AD. Inflammatory mechanisms in acute coronary syndromes: from pathophysiology to therapeutic targets. Cells. 2025, 15:72. 10.3390\/cells15010072","journal-title":"Cells"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1217-x","article-title":"Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka","volume":"19","author":"Ralapanawa U","year":"2019","unstructured":"Ralapanawa U, Kumarasiri PV, Jayawickreme KP, Kumarihamy P, Wijeratne Y, Ekanayake M, Dissanayake C. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovasc Disord. 2019, 19:229. 10.1186\/s12872-019-1217-x","journal-title":"BMC Cardiovasc Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome","volume":"83","author":"Kimura K","year":"2019","unstructured":"Kimura K, Kimura T, Ishihara M, et al.. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019, 83:1085-1196. 10.1253\/circj.CJ-19-0133","journal-title":"Circ J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/2048872620935399","article-title":"Performance of the European Society of Cardiology 0\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin: systematic review and meta-analysis","volume":"10","author":"Burgos LM","year":"2021","unstructured":"Burgos LM, Trivi M, Costabel JP. Performance of the European Society of Cardiology 0\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin: systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2021, 10:279-286. 10.1177\/2048872620935399","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.0031","article-title":"Performance of the European Society of Cardiology 0\/1-hour algorithm with high-sensitivity cardiac troponin T among patients with known coronary artery disease","volume":"8","author":"Ashburn NP","year":"2023","unstructured":"Ashburn NP, Snavely AC, O'Neill JC, et al.. Performance of the European Society of Cardiology 0\/1-hour algorithm with high-sensitivity cardiac troponin T among patients with known coronary artery disease. JAMA Cardiol. 2023, 8:347-356. 10.1001\/jamacardio.2023.0031","journal-title":"JAMA Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department with high-sensitivity troponin T study (RAPID-TnT)","volume":"140","author":"Chew DP","year":"2019","unstructured":"Chew DP, Lambrakis K, Blyth A, et al.. A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department with high-sensitivity troponin T study (RAPID-TnT). Circulation. 2019, 140:1543-1556. 10.1161\/CIRCULATIONAHA.119.042891","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.08.099","article-title":"The utility of the 1-hour high-sensitivity cardiac troponin T algorithm compared with and combined with five early rule-out scores in high-acuity chest pain emergency patients","volume":"322","author":"Ruangsomboon O","year":"2021","unstructured":"Ruangsomboon O, Thirawattanasoot N, Chakorn T, et al.. The utility of the 1-hour high-sensitivity cardiac troponin T algorithm compared with and combined with five early rule-out scores in high-acuity chest pain emergency patients. Int J Cardiol. 2021, 322:23-28. 10.1016\/j.ijcard.2020.08.099","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2017-207172","article-title":"Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events","volume":"35","author":"Reaney PD","year":"2018","unstructured":"Reaney PD, Elliott HI, Noman A, Cooper JG. Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events. Emerg Med J. 2018, 35:420-427. 10.1136\/emermed-2017-207172","journal-title":"Emerg Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20190417","article-title":"Association between clinical risk score (heart, grace, and TIMI) and angiographic complexity in acute coronary syndrome without ST-segment elevation","volume":"117","author":"Cedro AV","year":"2021","unstructured":"Cedro AV, Mota DM, Ohe LN, Timerman A, Costa JR, Castro LS. Association between clinical risk score (heart, grace, and TIMI) and angiographic complexity in acute coronary syndrome without ST-segment elevation. Arq Bras Cardiol. 2021, 117:281-287. 10.36660\/abc.20190417","journal-title":"Arq Bras Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2015.06.009","article-title":"Risk stratification in non-ST elevation acute coronary syndromes: risk scores, biomarkers and clinical judgment","volume":"8","author":"Corcoran D","year":"2015","unstructured":"Corcoran D, Grant P, Berry C. Risk stratification in non-ST elevation acute coronary syndromes: risk scores, biomarkers and clinical judgment. Int J Cardiol Heart Vasc. 2015, 8:131-137. 10.1016\/j.ijcha.2015.06.009","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1017\/S1049023X23006490","article-title":"Comparing TIMI, HEART, and GRACE risk scores to predict angiographic severity of coronary artery disease and 30-day major adverse cardiac events in emergency department patients with NSTEACS","volume":"38","author":"Yalcin Ocak N","year":"2023","unstructured":"Yalcin Ocak N, Yesilaras M, Kilicaslan B, Eyler Y, Mutlu \u0130, Kutlu M. Comparing TIMI, HEART, and GRACE risk scores to predict angiographic severity of coronary artery disease and 30-day major adverse cardiac events in emergency department patients with NSTEACS. Prehosp Disaster Med. 2023, 38:740-748. 10.1017\/S1049023X23006490","journal-title":"Prehosp Disaster Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12020048","article-title":"Coronary CT angiography in the emergency department: state of the art and future perspectives","volume":"12","author":"De Vita A","year":"2025","unstructured":"De Vita A, Covino M, Pontecorvo S, et al.. Coronary CT angiography in the emergency department: state of the art and future perspectives. J Cardiovasc Dev Dis. 2025, 12:48. 10.3390\/jcdd12020048","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ecm2030046","article-title":"Coronary CT angiography for acute chest pain in the emergency department: a systematic review of clinical utility","volume":"2","author":"Irannejad K","year":"2025","unstructured":"Irannejad K, Hubbard L, Narashim A, et al.. Coronary CT angiography for acute chest pain in the emergency department: a systematic review of clinical utility. Emerg Care Med. 2025, 2:46. 10.3390\/ecm2030046","journal-title":"Emerg Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2025.07.020","article-title":"Coronary computed tomography angiography for assessment of suspected acute coronary syndrome in the emergency department","volume":"78","author":"Finch AS","year":"2025","unstructured":"Finch AS, Keim SM, Bellamkonda VR, Carpenter CR, Mattu A. Coronary computed tomography angiography for assessment of suspected acute coronary syndrome in the emergency department. J Emerg Med. 2025, 78:71-77. 10.1016\/j.jemermed.2025.07.020","journal-title":"J Emerg Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw005","article-title":"Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department","volume":"37","author":"Ferencik M","year":"2016","unstructured":"Ferencik M, Hoffmann U, Bamberg F, Januzzi JL. Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department. Eur Heart J. 2016, 37:2397-2405. 10.1093\/eurheartj\/ehw005","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31922-5","article-title":"Optical coherence tomography compared with intravascular ultrasound and angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial","volume":"388","author":"Ali ZA","year":"2016","unstructured":"Ali ZA, Maehara A, G\u00e9n\u00e9reux P, et al.. Optical coherence tomography compared with intravascular ultrasound and angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016, 388:2618-2628. 10.1016\/S0140-6736(16)31922-5","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-0644","article-title":"Diagnostic performance of high-resolution intravascular ultrasound for the detection of plaque rupture in patients with acute coronary syndrome","volume":"83","author":"Ohashi H","year":"2019","unstructured":"Ohashi H, Ando H, Takashima H, et al.. Diagnostic performance of high-resolution intravascular ultrasound for the detection of plaque rupture in patients with acute coronary syndrome. Circ J. 2019, 83:2505-2511. 10.1253\/circj.CJ-19-0644","journal-title":"Circ J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15141822","article-title":"Machine learning for coronary plaque characterization: a multimodal review of OCT, IVUS, and CCTA","volume":"15","author":"Pinna A","year":"2025","unstructured":"Pinna A, Boi A, Mannelli L, Balestrieri A, Sanfilippo R, Suri J, Saba L. Machine learning for coronary plaque characterization: a multimodal review of OCT, IVUS, and CCTA. Diagnostics (Basel). 2025, 15:1822. 10.3390\/diagnostics15141822","journal-title":"Diagnostics (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305861","article-title":"Optical coherence tomography-guided versus angiography-guided PCI","volume":"389","author":"Ali ZA","year":"2023","unstructured":"Ali ZA, Landmesser U, Maehara A, et al.. Optical coherence tomography-guided versus angiography-guided PCI. N Engl J Med. 2023, 389:1466-1476. 10.1056\/NEJMoa2305861","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071885","article-title":"The evolving field of acute coronary syndrome management: a critical appraisal of the 2023 European Society of cardiology guidelines for the management of acute coronary syndrome","volume":"13","author":"Licordari R","year":"2024","unstructured":"Licordari R, Costa F, Garcia-Ruiz V, et al.. The evolving field of acute coronary syndrome management: a critical appraisal of the 2023 European Society of cardiology guidelines for the management of acute coronary syndrome. J Clin Med. 2024, 13:1885. 10.3390\/jcm13071885","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne RA","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023, 44:3720-3826. 10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4760","article-title":"Acute coronary syndromes: summary of updated NICE guidance","volume":"372","author":"Corbett SJ","year":"2021","unstructured":"Corbett SJ, Ftouh S, Lewis S, Lovibond K. Acute coronary syndromes: summary of updated NICE guidance. BMJ. 2021, 372:m4760. 10.1136\/bmj.m4760","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-025-02217-8","article-title":"Reevaluating STEMI: the utility of the occlusive myocardial infarction classification to enhance management of acute coronary syndromes","volume":"27","author":"Ayyad M","year":"2025","unstructured":"Ayyad M, Albandak M, Gala D, Alqeeq B, Baniowda M, Pally J, Allencherril J. Reevaluating STEMI: the utility of the occlusive myocardial infarction classification to enhance management of acute coronary syndromes. Curr Cardiol Rep. 2025, 27:75. 10.1007\/s11886-025-02217-8","journal-title":"Curr Cardiol Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07056-z","article-title":"Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized trials","volume":"35","author":"Ray A","year":"2021","unstructured":"Ray A, Najmi A, Khandelwal G, Jhaj R, Sadasivam B. Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized trials. Cardiovasc Drugs Ther. 2021, 35:561-574. 10.1007\/s10557-020-07056-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke S","year":"2019","unstructured":"Sch\u00fcpke S, Neumann FJ, Menichelli M, et al.. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019, 381:1524-1534. 10.1056\/NEJMoa1908973","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa670","article-title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","volume":"41","author":"Baber U","year":"2020","unstructured":"Baber U, Dangas G, Angiolillo DJ, et al.. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. Eur Heart J. 2020, 41:3533-3545. 10.1093\/eurheartj\/ehaa670","journal-title":"Eur Heart J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-00145","article-title":"Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes","volume":"16","author":"Franzone A","year":"2020","unstructured":"Franzone A, McFadden EP, Leonardi S, et al.. Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes. EuroIntervention. 2020, 16:627-633. 10.4244\/EIJ-D-20-00145","journal-title":"EuroIntervention"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron DJ","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, et al.. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020, 382:1395-1407. 10.1056\/NEJMoa1915922","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2174\/1574884715666200518091359","article-title":"The role of direct oral anticoagulant in patients with acute coronary syndrome on single or dual antiplatelet regime: review of opportunities and challenges","volume":"16","author":"Elnour AA","year":"2021","unstructured":"Elnour AA, Kom\u00f3csi A, Kup\u00f3 P, et al.. The role of direct oral anticoagulant in patients with acute coronary syndrome on single or dual antiplatelet regime: review of opportunities and challenges. Curr Rev Clin Exp Pharmacol. 2021, 16:52-63. 10.2174\/1574884715666200518091359","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14092914","article-title":"Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide","volume":"14","author":"Miceli G","year":"2025","unstructured":"Miceli G, Ciaccio AM, Tuttolomondo A. Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide. J Clin Med. 2025, 14:2914. 10.3390\/jcm14092914","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684638","article-title":"Direct oral anticoagulants: from randomized clinical trials to real-world clinical practice","volume":"12","author":"Roberti R","year":"2021","unstructured":"Roberti R, Iannone LF, Palleria C, et al.. Direct oral anticoagulants: from randomized clinical trials to real-world clinical practice\r\n. Front Pharmacol. 2021, 12:684638. 10.3389\/fphar.2021.684638","journal-title":"Front Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: A new lipid-lowering therapy","volume":"878","author":"Gallego-Colon E","year":"2020","unstructured":"Gallego-Colon E, Daum A, Yosefy C. Statins and PCSK9 inhibitors: A new lipid-lowering therapy. Eur J Pharmacol. 2020, 878:173114. 10.1016\/j.ejphar.2020.173114","journal-title":"Eur J Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine MS","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al.. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017, 376:1713-1722. 10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034576","article-title":"Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors","volume":"52","author":"Sanz-Cuesta BE","year":"2021","unstructured":"Sanz-Cuesta BE, Saver JL. Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors. Stroke Vasc Interv Neurol. 2021, 52:3142-3150. 10.1161\/STROKEAHA.121.034576","journal-title":"Stroke Vasc Interv Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz GG","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, et al.. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018, 379:2097-2107. 10.1056\/NEJMoa1801174","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.054610","article-title":"Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial","volume":"144","author":"Tong DC","year":"2021","unstructured":"Tong DC, Bloom JE, Quinn S, et al.. Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial. Circulation. 2021, 144:1584-1586. 10.1161\/CIRCULATIONAHA.121.054610","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu M","year":"2024","unstructured":"Yu M, Yang Y, Dong SL, et al.. Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial. Circulation. 2024, 150:981-993. 10.1161\/CIRCULATIONAHA.124.069808","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa782","article-title":"Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial","volume":"41","author":"Liuzzo G","year":"2020","unstructured":"Liuzzo G, Patrono C. Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial. Eur Heart J. 2020, 41:3880-3881. 10.1093\/eurheartj\/ehaa782","journal-title":"Eur Heart J"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.08.009","article-title":"Colchicine for prevention of atherothrombotic events in patients with coronary artery disease: review and practical approach for clinicians","volume":"37","author":"Marquis-Gravel G","year":"2021","unstructured":"Marquis-Gravel G, Goodman SG, Anderson TJ, et al.. Colchicine for prevention of atherothrombotic events in patients with coronary artery disease: review and practical approach for clinicians. Can J Cardiol. 2021, 37:1837-1845. 10.1016\/j.cjca.2021.08.009","journal-title":"Can J Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01370-6","article-title":"Updates in anti-anginal and anti-ischemic therapies for acute coronary syndromes","volume":"22","author":"Deoker A","year":"2020","unstructured":"Deoker A, Lehker A, Mukherjee D. Updates in anti-anginal and anti-ischemic therapies for acute coronary syndromes. Curr Cardiol Rep. 2020, 22:126. 10.1007\/s11886-020-01370-6","journal-title":"Curr Cardiol Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/JXX.0000000000001195","article-title":"Comparative analysis of 2025 American College of Cardiology\/American Heart Association\/Multisociety and 2023 European Society of Cardiology acute coronary syndrome guidelines: implications for advanced practice registered nurses","volume":"38","author":"Farfan Medina LE","year":"2026","unstructured":"Farfan Medina LE. Comparative analysis of 2025 American College of Cardiology\/American Heart Association\/Multisociety and 2023 European Society of Cardiology acute coronary syndrome guidelines: implications for advanced practice registered nurses. J Am Assoc Nurse Pract. 2026, 38:89-99. 10.1097\/JXX.0000000000001195","journal-title":"J Am Assoc Nurse Pract"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072354","article-title":"Intersections and challenges in the management of acute coronary syndrome and stroke: pathophysiology, treatment dilemmas, and integrated prevention strategies","volume":"14","author":"Carella MC","year":"2025","unstructured":"Carella MC, Carulli E, Loizzi F, et al.. Intersections and challenges in the management of acute coronary syndrome and stroke: pathophysiology, treatment dilemmas, and integrated prevention strategies. J Clin Med. 2025, 14:2354. 10.3390\/jcm14072354","journal-title":"J Clin Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071723","article-title":"Genomic and precision medicine approaches in atherosclerotic cardiovascular disease: from risk prediction to therapy - a review","volume":"13","author":"Mitsis A","year":"2025","unstructured":"Mitsis A, Khattab E, Kyriakou M, et al.. Genomic and precision medicine approaches in atherosclerotic cardiovascular disease: from risk prediction to therapy - a review. Biomedicines. 2025, 13:1723. 10.3390\/biomedicines13071723","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495254-advances-in-the-diagnosis-and-management-of-acute-coronary-syndrome-a-clinical-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:51:47Z","timestamp":1780743107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495254-advances-in-the-diagnosis-and-management-of-acute-coronary-syndrome-a-clinical-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.110344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}